Gene sequence construct for gene therapy of human immunodeficiency virus infection
US-2024352096-A1 · Oct 24, 2024 · US
Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV] · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/114 |
| Official title | Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV] |
| Display label | Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV] |
| Total patents | 329 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 14 |
| 2016 | 17 |
| 2017 | 11 |
| 2018 | 33 |
| 2019 | 28 |
| 2020 | 27 |
| 2021 | 40 |
| 2022 | 41 |
| 2023 | 39 |
| 2024 | 38 |
| 2025 | 34 |
| 2026 | 7 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Immunoassemblin (ia) protein complexes
US-2018311326-A1 · Nov 1, 2018 · US
B cell lineage based immunogen design with humanized animals
US-2018298082-A1 · Oct 18, 2018 · US
High-throughput mouse model for optimizing antibody affinities
US-2018295822-A1 · Oct 18, 2018 · US
Therapeutic compounds and methods
US-2018282386-A1 · Oct 4, 2018 · US
Method of Redirecting T Cells to Treat HIV Infection
US-2018265565-A1 · Sep 20, 2018 · US
Subcutaneous reservoir device and method of manufacture
US-2018235900-A1 · Aug 23, 2018 · US
Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
US-2018228890-A1 · Aug 16, 2018 · US
Antibodies targeting hiv escape mutants
US-2018230203-A1 · Aug 16, 2018 · US
Neutralizing GP41 antibodies and their use
US-10047148-B2 · Aug 14, 2018 · US
Neutralizing GP41 antibodies and their use
US-10047147-B2 · Aug 14, 2018 · US
Broadly-neutralizing anti-HIV antibodies
US-10047146-B2 · Aug 14, 2018 · US
High-throughput mouse model for optimizing antibody affinities
US-10034463-B2 · Jul 31, 2018 · US
B cell lineage based immunogen design with humanized animals
US-9963501-B2 · May 8, 2018 · US
Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors
US-9951118-B2 · Apr 24, 2018 · US
Broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibody
US-2018057570-A1 · Mar 1, 2018 · US
Structured viral peptide compositions and methods of use
US-2018037636-A1 · Feb 8, 2018 · US
Neutralizing gp41 antibodies and their use
US-2018002406-A1 · Jan 4, 2018 · US
Methods for modular synthesis of n-glycans and arrays thereof
US-2017362265-A1 · Dec 21, 2017 · US
Antibodies With Simultaneous Subsite Specificities To Protein and Lipid Epitopes
US-2017342135-A1 · Nov 30, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/114?
- CPC C07K16/114 is the Cooperative Patent Classification code for “Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV].”
- How many patents are filed under CPC C07K16/114 (Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV])?
- Our database includes 329 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/114 growing?
- Publication counts under this code: 38 in 2024 vs 34 in 2025 (latest complete years).